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ABSTRACT Passive tension in striated muscles derives primarily from the extension of the giant protein titin. However,
several studies have suggested that, in cardiac muscle, interactions between titin and actin might also contribute to passive
tension. We expressed recombinant fragments representing the subdomains of the extensible region of cardiac N2B titin
(tandem-Ig segments, the N2B splice element, and the PEVK domain), and assayed them for binding to F-actin. The PEVK
fragment bound F-actin, but no binding was detected for the other fragments. Comparison with a skeletal muscle PEVK
fragment revealed that only the cardiac PEVK binds actin at physiological ionic strengths. The significance of PEVK–actin
interaction was investigated using in vitro motility and single-myocyte mechanics. As F-actin slid relative to titin in the motility
assay, a dynamic interaction between the PEVK domain and F-actin retarded filament sliding. Myocyte results suggest that
a similar interaction makes a significant contribution to the passive tension. We also investigated the effect of calcium on
PEVK–actin interaction. Although calcium alone had no effect, S100A1, a soluble calcium-binding protein found at high
concentrations in the myocardium, inhibited PEVK–actin interaction in a calcium-dependent manner. Gel overlay analysis
revealed that S100A1 bound the PEVK region in vitro in a calcium-dependent manner, and S100A1 binding was observed at
several sites along titin’s extensible region in situ, including the PEVK domain. In vitro motility results indicate that
S100A1–PEVK interaction reduces the force that arises as F-actin slides relative to the PEVK domain, and we speculate that
S100A1 may provide a mechanism to free the thin filament from titin and reduce titin-based tension before active contraction.
INTRODUCTION
Titin is a giant protein that spans the length of the half-
sarcomere to form a third filament system (in addition to the
thin and thick filaments) in vertebrate striated muscle (for
recent reviews see Wang 1996; Labeit et al., 1997; Gregorio
et al., 1999; Trinick and Tskhovrebova 1999). In the I-band,
titin filaments exhibit elastic behavior upon sarcomere
stretch, resulting in a force that is a primary contributor to
the passive tension of cardiac muscle (Granzier and Irving
1995; Wu et al., 2000). Differential splicing of titin’s pri-
mary transcript produces two classes of cardiac titin iso-
forms, referred to as N2B and N2BA (Freiburg et al., 2000),
that differ in their expression patterns in various species.
The hearts of small mammals, such as mouse and rat,
express predominantly N2B titin, whereas larger mammals,
including humans, co-express N2B and N2BA titins (Ca-
zorla et al., 2000). The extensible region of N2B titin
contains three subdomains: tandem Ig segments, that consist
of tandemly-linked immunoglobulin (Ig)-like domains; the
cardiac-specific N2B splice element, which includes a 572-
residue unique sequence; and the 163-residue PEVK do-
main, which contains 70% (P) proline, (E) glutamic acid,
(V) valine, and (K) lysine (Labeit and Kolmerer 1995).
N2BA titins contain a much longer PEVK segment than
N2B titins (600–800 verses 163 residues), as well as an
additional tandem Ig segment and the differentially spliced
N2A element (Freiburg et al., 2000). As a result, N2BA titin
has a longer extensible region and higher molecular mass
than N2B titin (3.3 versus 2.97 MDa).
Immunolabeling and mechanical experiments have
shown that the subsegments of titin’s extensible region
behave as variable-stiffness entropic springs linked in series
(Linke et al., 1998a, 1998b; Trombitas et al., 1998b). As
sarcomeres are stretched from their slack length, the low-
stiffness tandem-Ig segments extend preferentially at short
sarcomere lengths (SL), resulting in low levels of passive
tension, whereas the stiffer N2B unique sequence and
PEVK domain extend at intermediate to long SLs, resulting
in high levels of passive tension (Helmes et al., 1999; Linke
et al., 1999). The tandem Ig segments thus act as a “molec-
ular leash” that determines the SL range in which titin’s
primary force-generating elements, the N2B unique se-
quence and the PEVK domain, operate.
Recent studies have suggested that passive tension in
cardiac muscle may not be solely determined by titin’s
intrinsic elasticity, but may also include contributions from
titin–actin interaction (Granzier et al., 1997; Stuyvers et al.,
1997a,b, 1998, 2000). This suggestion is supported by
titin’s close proximity to the thin filament in the I-band, and
by previous reports of binding between titin and actin, both
in vitro and in situ (Kimura et al., 1984; Funatsu et al., 1993;
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Jin 1995; Kellermayer and Granzier 1996a,b; Linke et al.,
1997; Trombitas and Granzier 1997). Of particular interest
are potential interactions involving titin’s extensible region,
because these would be most likely to influence the passive
mechanical properties of cardiac muscle.
To study titin–actin interaction, we expressed recombi-
nant fragments representing the subdomains comprising
titin’s extensible region, and surveyed them for binding to
F-actin. Because animal models that express predominantly
N2B titin (mouse and rat) have been extensively studied and
are readily available, we focused our work on the N2B
isoform. Our results reveal that only the PEVK region of
N2B titin binds F-actin. We also studied a second PEVK
fragment expressed in skeletal muscle titins, and found that,
although it can also bind F-actin, the binding is weaker than
that observed with the N2B PEVK, and does not occur at
physiological ionic strengths (IS). These results suggest
that, within titin’s extensible segment, the cardiac N2B
PEVK domain may be unique in its ability to bind F-actin.
The physiological significance of PEVK–actin interac-
tion was investigated using an in vitro motility assay tech-
nique and mechanical experiments with single mouse car-
diac myocytes. Our findings suggest that, as the thin
filament slides relative to titin during passive muscle
stretch, a dynamic interaction between the PEVK domain
and F-actin results in a force that opposes filament sliding
and enhances passive tension. We also explored potential
calcium effects on PEVK–actin interaction. Although cal-
cium alone exerted no effect, we found that S100A1, a
member of the S100 family of EF-hand calcium binding
proteins, regulates PEVK–actin interaction in a calcium-
dependent manner. The regulation of PEVK–actin interac-
tion by calcium/S100A1 may provide a mechanism to free
the thin filament from titin before active contraction, and to
reduce titin-based force during systole.
MATERIALS AND METHODS
Recombinant titin fragments
Titin cDNA fragments (Fig. 1A) were amplified by polymerase chain
reaction (PCR) using primer pairs derived from human cardiac N2B titin
(EMBL data library accession X90568) and human soleus skeletal muscle
titin (accession X90569). Fragments were cloned into modified pET vec-
tors, expressed in BL21[DE3]pLysS cells, and purified from the soluble
fraction on Ni-NTA columns with a His-Bind purification kit (Novagen,
Madison, WI). Fragment boundaries from the human cardiac N2B peptide
sequence corresponded to: I91–I98 (residues 5237–5959), I91–I94 (5237–
5591), I27-PEVK-I84 (residues 4337–4713), and uN2B (residues 3671–
4242). The skeletal muscle PEVK fragment (sPEVK) included residues
5898–6377 of the human soleus peptide sequence. All fragments were
purified under native conditions, except I27-PEVK-I84, which degraded
and aggregated under these conditions. I27-PEVK-I84 was thus column-
purified in the presence of 6M GuCl and 10 mM glutathione, and refolded
while bound to the column via a gradient-to-native binding buffer ((mM)
5 imidazole, 500 NaCl, 20 tris-HCl, pH 7.9) as described previously (Zahn
et al., 1997). This treatment reduced aggregation and significantly in-
creased the purity of the preparation (Fig. 1 B). Samples were then quick
frozen in liquid nitrogen and stored at 80°C. Upon thawing, I27-PEVK-
I84 sometimes contained a small fraction of aggregate species. Therefore,
samples were thawed immediately before all experiments, and residual
aggregates were removed via centrifugation for 30 min in a Beckman
Airfuge at 30 psi. The samples were then stored on ice and used within 1 h.
Circular dichroism spectroscopic measurements were performed to ensure
that the Ig-like domains flanking the PEVK domain (I27 and I84) were
properly folded during purification (Fig. 1C). Our results are similar to
those obtained previously for I91 (Politou et al., 1995; here referred to as
I27), with a maximum at 200 nm, and a minimum at 212 nm. The
-sheet content of our fragment was estimated at57% using the software
program CD ESTIMA (based on Chang et al., 1978). This value is
consistent with previous estimates for a titin Ig-like domain (Politou et al.,
1994). All fragments were dialyzed into (mM) 100 KCl, 25 imidazole (pH
7.4) and 1 DTT before use, and protein concentrations were determined via
the Bradford method (Bradford, 1976). Theoretical isoelectric points were
calculated with the MW/PI calculator at http://www.expasy.ch.
Proteins
Actin, myosin, and heavy meromyosin (HMM) were purified according to
the methods of Pardee and Spudich (1982), Margossian and Lowey (1982),
and Kron et al. (1991), respectively. The purity of protein preparations was
monitored by SDS-gel electrophoresis on 12% gels, and concentrations
were determined via absorbance at 280 nm using molar extinction coeffi-
cients of 1.1 cm1, 0.53 cm1, and 0.6 cm1 for actin, myosin, and HMM,
respectively. F-actin was fluorescently labeled with a 1.5X molar excess of
tetramethyl-rhodamine-isothiocyanate-conjugated phalloidin (Molecular
Probes, Eugene, OR) and S100A1 was purchased from Calbiochem (La
Jolla, CA; catalog #559287).
Co-sedimentation assay
F-actin was incubated at room temperature for 20 min with recombinant
titin fragments in co-sedimentation buffer ((mM) 100 KCl, 25 Imidazole-
HCl (pH 7.4), 1.5 MgCl2, 1 ATP, 1 DTT, and either 1 EGTA or 0.1 CaCl2)
in a total volume of 50 l. The mixtures were then sedimented in a
Beckman Airfuge at 28 psi for 30 min. After removing the supernatants,
pellets were washed with 100 l co-sedimentation buffer, and allowed to
stand in an additional 50 l co-sedimentation buffer. The pellets and
supernatants were solubilized at 90°C for 3 min with 25 l of 3X solubi-
lization buffer (Laemmli 1970), electrophoresed on 12% SDS gels, and
stained with Coomassie Blue. The gels were then scanned with an Epson
800 optical scanner, and densitometry was performed using the One-D-
Scan software program (v.1.31, Scanalytics Corporation). For Kd determi-
nations, data were fit with a one-site saturable binding function (Y 
Bmax*X/Kd  X).
Fluorescent surface-binding assay
The visual binding assay was carried out essentially according to Keller-
mayer and Granzier (1996a). Experiments were performed in a flow-
through microchamber with an internal volume of 10 l, whose surface
was coated with 1% nitrocellulose (Ernest Fullam, Latham, NY). Fluores-
cent F-actin was sheared three times with a 27-gauge needle before use to
give a uniform length distribution (estimated mean length 1–2 m).
Solutions were added to the assay chamber in the following order: Exper-
iments in Fig. 3: (l) 25 PEVK, 100 1-mg/ml BSA (blocking), 100 wash
(twice), 100 fluorescent F-actin, and 100 wash, with 1-min incubation
periods following each step. All components were in buffer A ((mM) 25
imidazole-HCl (pH 7.4), 1.5 MgCl2 (free [Mg2] 1.5 mM), 1 DTT, and
KCl to achieve specified IS). Buffer A in PEVK and blocking steps had an
IS of 180 mM. For steps following blocking, buffer A contained 1 mM
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EGTA and had variable IS. Experiments in Fig. 8: (l) 25 PEVK, 100
1-mg/ml BSA (blocking), 100 wash (twice), 100 S100A1. (Wash in control
experiments), 100 1-mg/ml BSA, 100 wash, 100 fluorescent F-actin, and
100 wash, with 1-min incubation periods following each step. The IS of
buffer A was 180 mM, and, for steps following blocking, buffer A
contained 0.1 mM CaCl2 or 1 mM EGTA (see Fig. 8 A), or 1 mM EGTA
and CaCl2 to achieve specified pCa (see Fig. 8 B. Ionic strength and pCa
(log[Ca2]) were calculated using the software program of Fabiato
(1988). Experiments were carried out at room temperature. Fluorescent
actin filaments were visualized via epifluorescence microscopy and images
were captured and recorded as described previously (Kellermayer and
Granzier 1996a). Twenty randomly selected microscopic fields of view
(FOV) were recorded for each experiment, and the number of bound actin
filaments per FOV was measured using a user-developed program for
Scion Image image analysis software (v. 1.6; based on NIH Image, Na-
tional Institutes of Health, Bethesda, MD).
In vitro motility
In vitro motility experiments were carried out essentially according to Kron
et al. (1991), using the setup described by Kellermayer and Granzier
(1996a). The temperature was controlled at 27°C by a jacketed objective
thermostat. A flow-through chamber similar to that described for the
fluorescent surface-binding assay was used, with double-thickness spacers
and an internal volume of 20 l. Solutions were added to the assay
chamber in the following order: Experiments in Fig. 4: (l) 50 HMM or
HMM  PEVK (mixed immediately before use), 100 0.5-mg/ml BSA
(blocking), 100 wash (twice), 100 fluorescent F-actin, 100 0.5-mg/ml BSA,
100 motility buffer (supplemented with an enzyme cocktail to reduce
photo-bleaching (Kron et al., 1991), ATP to give a pMg-ATP of 3.0,
MgCl2 to give free [Mg] of 1.5 mM, and 0.7% w/v methylcellulose). All
components were in buffer B ((mM) 25 Imidazole-HCl (pH 7.4), 1.5
MgCl2, 1 EGTA, 1 DTT, and K-propionate to give IS of 140). Experiments
in Fig. 9: (l) 50 HMM or HMM/PEVK, 100 0.5-mg/ml BSA (blocking),
100 wash (twice), 100 3-M S100A1 (wash in control), 100 0.5-mg/ml
BSA, 100 wash, 100 fluorescent F-actin, 100 0.5-mg/ml BSA, 100 motility
buffer, as described above. All components were in buffer B with either 1
mM EGTA or 0.1 mM CaCl2, except the PEVK and blocking steps in
which EGTA/calcium was omitted. Each step in the motility experiments
was followed by a 1-min incubation at room temperature. Solution com-
positions were calculated according to Fabiato (1988).
Images of moving filaments were visualized, recorded, and digitized as
described by Kellermayer and Granzier (1996a). Filament velocities were
measured from digitized movies (30 frames; 10 frames/s) using user-
FIGURE 1 Recombinant titin fragments. (A) Domain organization of the extensible I-band segment of human cardiac titin (N2B isoform; accession
X90568), with the compositions of fragments denoted by lines under their corresponding locations in the sequence. (Domain numbering is according to
Freiburg et al.; 2000. (B) Coomassie stained 12% SDS-gel of I27-PEVK-I84. Lane 1 was purified under standard (native) conditions, and lane 2 was
column-purified under denaturing conditions and refolded while bound to the column. The denaturing/refolding procedure significantly enhanced the purity
of the preparation. The identity of the I27-PEVK-I84 band was confirmed via western blots with the 9D10 anti-PEVK antibody (Wang and Greaser; 1985;
Trombitas et al., 1998a; Greaser et al., 2000). (C) CD spectrum of denatured/refolded I27-PEVK-I84. The spectrum is similar to that determined previously
for the titin Ig-like domain I91 (see Methods), and indicates that I27 and I84 have likely assumed their proper -barrel structures.
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developed programs for the Scion Image software program. Velocities
were calculated by measuring the centroid positions of selected filaments
as a function of time. Completely or partially immobile filaments (those
with any part of the filament immobilized on the substrate for greater than
a 5-frame (0.5-s) interval) and those undergoing nontranslational move-
ment (e.g., spiraling as described by Gordon et al., 1997) were omitted
from analysis. Velocities were determined for 75 filaments in 5–10 FOV
for each experiment. A 10-m optical grating (VWR Scientific, Seattle
WA) was used for spatial calibration.
Capillary binding assay
The experimental protocol was similar to that described previously (Li et
al., 1995; Kellermayer and Granzier 1996a). Glass capillaries with an
internal volume of 100 l (VWR Scientific) were coated with 1% nitro-
cellulose (Ernest Fullam, Latham, NY), dried, and incubated with the
following solutions: 0.2 mg/ml PEVK (omitted in negative control), block-
ing solution (5% w/v BSA, 1% w/v gelatin), 0.5% w/v BSA (twice), 0.2
mg/ml HMM, and wash (5). All components were in 180 mM buffer A.
Bound proteins were then solubilized by repeatedly rinsing capillaries with
1X solubilization buffer (Laemmli 1970) at 90°C, electrophoresed on a
12% SDS-gel, and silver stained according to the method of Granzier and
Wang (1993).
Myocyte mechanics
Cardiac myocytes were isolated from mouse left ventricle according to the
method of Wolska and Solaro (1996), and skinned as described previously
(Granzier and Irving 1995). Passive tension–SL curves were obtained as
detailed in Helmes et al. (1999). Experiments were performed in an open
chamber with an internal volume of 300 l, and passive tension was
measured in relaxing solution ((mM) 25 imidazole-HCl (pH 7.4), 100 KCl,
7.5 Mg-acetate (free magnesium  3.55 mM), 5 EGTA, 3.3 ATP, 12
creatine phosphate, 1 DTT, 0.04 leupeptin, and 0.01 E-64). Cells were
activated with a pCa 4.5 (pCa adjusted with CaCO3) activating solution
before passive tension measurements to verify cell quality. Control passive
tension–SL relations were measured by applying a slow-ramp stretch–
release (0.1 lengths/s), and cells were then incubated in 2.8 M I27-
PEVK-I84 (achieved via 2 half-volume changes of the chamber solution
with 3.75 M I27-PEVK-I84 in relaxing solution, with 10- and 30-min
incubation periods after each change, respectively). Low-amplitude
stretch–releases (SL  1.9–2.2 m) were imposed every 5 min during
PEVK incubation to facilitate diffusion of the fragment. Passive ten-
sion–SL curves were then obtained in the presence of I27-PEVK-I84,
followed by washout of the fragment via continuous perfusion for 20 min,
and measurement of passive-tension-SL curves after washout. Experiments
were conducted at room temperature.
Gel overlay
Fragment I27-PEVK-I84 was electrophoresed (1 g/lane) on 12% SDS-
gels and transferred to PVDF membrane with constant current. To facilitate
transfer of the basic fragment (pI  9.7), blotting buffers were pH 11.7.
After transfer, membrane strips were washed extensively in distilled H2O,
followed by buffer C ((mM) 25 imidazole-HCl (pH 7.4), 4 MgCl2, 1 DTT,
either 1 EGTA or 0.1 CaCl2, 0.05% Tween-20 and KCl to give IS of 140).
The strips were then blocked with 0.5% w/v BSA and 0.2% w/v gelatin in
buffer C, washed with buffer C, and incubated for 30 min at room
temperature with biotinylated S100 (S100A1 was biotinylated with a
biotin-X-NHS kit (Molecular Probes) according to the suppliers instruc-
tions). After extensive washing with buffer C, the strips were incubated for
30 min with an avidin-conjugated alkaline phosphatase (Vector laborato-
ries, Burlingame, CA), washed with buffer C, and developed with Sig-
mafast BCIP/NBT substrate (Sigma, St. Louis, MO). Biotinylated S100
was excluded from negative control experiments. Scanning and densitom-
etry was performed as described for co-sedimentation assays.
Immunolabeling and electron microscopy
Left ventricular wall muscle was dissected from mouse hearts in
HEPES buffer ((mM) 10 HEPES (pH 7.4), 133.5 NaCl, 4 KCl, 1.2
NaHPO4, 1.2 MgSO4, and 11 D-glucose), and skinned overnight in
skinning buffer (relaxing solution with 1% triton X-100). Muscle strips
were dissected in skinning buffer, stretched to 10, 20, or 30% of their
slack length, and pinned to a Sylgard (Dow Corning Corporation,
Midland, MI) surface on the bottom of 100 l wells. The wells were
washed 20, for 3 min each with rigor buffer (RB) ((mM) 40 imida-
zole-HCl (pH 7.0), 10 EGTA, 0.5 Mg-acetate, 5 Na-azide, 140 K-
propionate, 0.4 leupeptin, 0.1 E-64, 0.5 PMSF, and 1 DTT) containing
2% triton X-100. After the rigor washes, plates were separated into 2
groups that were treated in all subsequent steps with RB, with (pCa 4.5)
or without (pCa 9) calcium. Wells were then washed an additional 5
in RB for 3 min each, followed by blocking with 0.5% (w/v) BSA in RB
for 30 min. After a 10-min wash with RB, the strips were incubated with
7.5 M S100A1 for 30 min (RB in controls), washed for 3 min in RB,
and lightly fixed with 0.3% paraformaldehyde in RB for 20 min.
Immunodetection and electron microscopy were performed as described
previously (Granzier et al., 1996) using a primary antibody to the S100
-subunit (Sigma, catalog# S-2407). Epitope distances with respect to
the Z-line were measured from scanned negatives of electron micro-
graphs using an user-developed program for Scion Image software.
RESULTS
The cardiac titin PEVK domain binds F-actin
Recombinant fragments representing the subdomains of
cardiac N2B titin’s elastic segment (tandem Ig segments,
the PEVK domain, and the N2B splice element) were
expressed in Escherichia coli and purified from the sol-
uble protein fractions. The fragments (Fig. 1 A) included:
the 572-residue unique sequence in the cardiac-specific
N2B element (uN2B); four and eight Ig-like domain
fragments from the distal tandem Ig segment (I91-I94
and I91-I97); and the N2B PEVK domain along with its
flanking Ig-like domains, I27 and I84 (I27-PEVK-I84).
To investigate potential interactions between F-actin and
titin’s extensible region, co-sedimentation assays were
performed. In the absence of F-actin, each of the frag-
ments was found predominantly in the supernatant,
whereas, in the presence of F-actin, only the PEVK
fragment was detected in the pellet (Fig. 2A). The ab-
sence of F-actin binding by I91-I97 indicates that the
binding exhibited by I27-PEVK-I84 is unlikely to be
mediated by the flanking Ig-like domains, and requires
the PEVK domain. The co-sedimentation results suggest
that the I27-PEVK-I84 region is unique within cardiac
titin’s extensible segment in its ability to bind F-actin.
However, there are subdomains within the extensible
segment that are not represented by our recombinant
fragments, and for which actin binding cannot be ex-
cluded. These include two of titin’s Ig-like domains in
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the proximal tandem Ig segment (I14 and I15) that con-
tain 10–15-residue C-terminal extensions (Witt et al.,
1998), and two additional unique sequence insertions (21
and 48 residues in length) in the N2B element (Fig. 1 A).
Future work will be required to determine whether these
regions can also bind F-actin.
The affinity of I27-PEVK-I84–F-actin interaction was
estimated via co-sedimentation (Fig. 2 B) with varying
concentrations of the PEVK fragment (1–5.5 M) and a
fixed amount of F-actin (2.5 M). Because there is a
previous report of a calcium-dependent interaction be-
tween thin filaments and purified full-length titin (Keller-
mayer and Granzier, 1996a), the experiments were con-
ducted in both the presence (0.1 mM CaCl2) and absence
(1 mM EGTA) of calcium. The data gave Kd values of
2.27  1.1 and 2.08  0.8 M in the presence and
absence of calcium, respectively. These values indicate
that titin’s PEVK region binds F-actin with moderate
affinity, in a manner that is unaffected by calcium. The
Kd values are also very similar to those recently reported
for F-actin binding to a fetal skeletal muscle PEVK
fragment (Kd  1–5 M) using an independent method
(Gutierrez-Cruz et al., 2000). The absence of a calcium
effect on PEVK–actin interaction suggests that the cal-
cium-dependent interaction observed by Kellermayer and
Granzier (1996a) was mediated by titin domains outside
of the regions examined in the present study.
PEVK–actin interaction occurs at physiological
ionic strengths
Interactions involving F-actin are often IS dependent, and
we thus performed additional binding studies to assess the
effect of IS on PEVK–actin interaction. For these studies, a
visual fluorescence assay was used similar to that described
previously by Kellermayer and Granzier (1996a). This ap-
proach has the advantage of requiring small quantities of
proteins, allowing F-actin interactions to be assayed under a
wide variety of conditions. Furthermore, the assay has only
one freely diffuseable binding partner. This arrangement
may be more relevant to conditions in the sarcomere, where
the thin filament is anchored in the Z-line.
Figure 3 A (left) shows a microscopic field of view with
fluorescent F-actin bound to a PEVK-coated surface. The
panel on the right shows a field with an absence of binding
to a BSA-coated surface (negative control). I91–I97 and
uN2B-coated surfaces displayed a similar absence of F-
actin binding (not shown). These results agree with our
co-sedimentation results, and indicate that, within titin’s
extensible segment, the PEVK region is unique in its ability
to bind F-actin. Figure 3 B (squares) shows the relative
degree of binding between F-actin and the I27-PEVK-I84 as
a function of IS . The binding is unaffected by increased IS
to a value of170 mM. At values greater than 170 mM, the
number of bound filaments decreased with increasing IS.
Half-maximal binding was observed at an IS of 190 mM.
The interaction between F-actin and the PEVK fragment is
thus sensitive to the IS, while being significant within the
physiological range in striated muscle (170–200 mM;
Maughan and Godt 1989).
Because of a recent report of F-actin binding to a fetal
skeletal muscle PEVK fragment (Gutierrez-Cruz et al.,
2000), we also expressed an 500-residue skeletal
PEVK fragment (sPEVK) and tested whether it bound
F-actin in the visual binding assay. No binding was
observed when the sPEVK fragment was added to the
assay chamber at the same concentration as I27-PEVK-
I84. Upon introducing successively higher concentrations
of sPEVK, significant binding was observed at interme-
diate (110 mM) IS with an sPEVK concentration approx-
imately 10-fold higher than that used for I27-PEVK-I84.
FIGURE 2 Survey of actin-binding propensities along titin’s extensi-
ble region. (A) Co-sedimentation assay. Fragments (2.75 M) repre-
senting the subsegments comprising titin’s extensible region (tandem-
Igs (I91–I98), N2B element (uN2B), and the PEVK domain (I27-
PEVK-I84)) were assayed for binding to F-actin (5 M). In control
experiments, the fragments were found in the supernatant, whereas, in
the presence of F-actin, only I27-PEVK-I84 was detected in the pellet.
(B) Kd determination for F-actin binding to I27-PEVK-I84. 2.5 M
F-actin was incubated with varying concentrations of I27-PEVK-I84
(5.6 –1.1 M) in the presence (0.1 mm CaCl2; squares) or absence (1
mM EGTA, circles) of calcium. Densitometric analysis yielded Kd
values of 2.27  1.1 and 2.0  0.8 M in the presence and absence of
calcium, respectively.
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The observed binding exhibited an enhanced IS sensitiv-
ity, however, and no binding could be detected at IS
values greater than 145 (Fig. 3 B, circles). These findings
indicate that, although the sPEVK fragment can interact
with F-actin, it binds with a much weaker affinity and
increased IS sensitivity compared to the cardiac PEVK.
Gutierrez-Cruz et al. (2000) found similar properties with
a fetal skeletal muscle PEVK fragment, which bound
F-actin at intermediate, but not physiological levels of IS.
The results of the binding studies conducted with skeletal
PEVK fragments therefore suggest that only the cardiac
N2B PEVK domain can bind F-actin under physiological
IS conditions.
PEVK–actin interaction inhibits in vitro motility
The elastic behavior of the cardiac PEVK domain in vivo
requires that an interaction between it and the thin filament
be dynamic in nature. An in vitro motility assay technique
was therefore used to investigate the physiological signifi-
cance of PEVK–actin interaction under dynamic conditions.
The velocities of actin filaments sliding over a surface
FIGURE 3 Fluorescent surface-binding assay. (A) Left: Microscopic image showing fluorescently labeled F-actin bound to a surface coated with
I27-PEVK-I84. Right: F-actin did not bind to a BSA-coated surface. (B) Binding as a function of IS. The mean number of actin filaments bound per
microscopic FOV to 0.3 M I27-PEVK-I84 (squares) and to 2.5 M sPEVK, an 500-residue skeletal muscle PEVK fragment (circles), as a function of
IS. I27-PEVK-I84 binds F-actin at physiological (170–200) IS, whereas sPEVK does not. N  5 experiments at each IS, with bound filaments counted
for 20 FOV in each experiment. Error bars are  SD.
2302 Yamasaki et al.
Biophysical Journal 81(4) 2297–2313
coated with either HMM or a mixture of HMM and the
PEVK fragment were measured in the presence of 1 mM
EGTA. This protocol simulates the arrangement in passive
muscle, where the thin filaments slide relative to titin as
sarcomeres are stretched.
The PEVK fragment inhibited sliding velocities in a
concentration-dependent manner (Fig. 4, circles), with an
0.5 M concentration of the fragment resulting in a
70% decrease in velocity relative to the control (HMM
only). To test for nonspecific effects, a fragment containing
the Ig-like domains I91–I94 from titin’s proximal tandem Ig
segment was used in parallel experiments. The four-domain
I91–I94 fragment, which has a similar molecular weight to
the PEVK fragment, had no significant effect on sliding
velocities relative to the control when added at the highest
concentration used in the PEVK experiments (Fig. 4,
square). There was also no binding detected between HMM
and I27-PEVK-I84 using a capillary binding assay (not
shown) similar to that described previously (Li et al., 1995;
Kellermayer and Granzier, 1996a). We conclude that a
dynamic interaction between F-actin and the PEVK domain
results in a force that opposes the HMM-based motile force.
This raises the possibility that a similar force arises as the
thin filaments are translocated relative to titin in passively
stretched sarcomeres. Such a force could make a significant
contribution to the passive tension, as suggested by the
passive tension decrease measured by Granzier et al. (1997)
in response to selective thin filament extraction in rat car-
diomyocytes.
PEVK–actin interaction contributes to
passive tension
To probe whether PEVK–actin interaction can affect the
development of passive tension, mechanical experiments
with mouse cardiac myocytes were performed. The passive
tension–SL relation of skinned myocytes (n  5) was mea-
sured before and after incubation with I27-PEVK-I84, and
again after the subsequent washout of the fragment. If the
PEVK domain binds actin in the myocyte, the exogenous
I27-PEVK-I84 could compete with native titin molecules
for binding sites along the thin filament. The addition of the
PEVK fragment therefore provides a measure of the effect
of PEVK–actin interaction on passive tension generation by
“competing-off” endogenous PEVK–actin interactions. Fig-
ure 5 A shows passive tension–SL curves for a representa-
tive cell, and Fig. 5 B shows the mean passive tensions
versus SL for all cells (relative to control values) in the
presence of the PEVK fragment (circles) and after washout
of the fragment (squares). The addition of the PEVK frag-
ment significantly decreased passive tension at all SLs, with
the magnitude of the decrease inversely related to SL. The
mean decrease across all SLs tested was 20%, and 45%
of this decrease was recovered across all SL after washout
of the fragment. In a recent study (C. Muhle-Goll, M.
Habeck, O. Cazorla, M. Nilgos, S. Labeit, and H. Granzier,
submitted for publication), incubating skinned mouse left
ventricular myocytes with recombinant fragments from
titin’s A-band and Z-line regions had no effect on passive
tension. These findings indicate that recombinant proteins
do not affect passive tension nonspecifically, and suggest
that the observed decrease is mediated by the actin-binding
properties of I27-PEVK-I84.
S100A1 binds to the cardiac PEVK domain
in vitro and in situ
S100A1 is a member of the S100 family of E-F hand
calcium-binding proteins, and is the predominant S100 iso-
form present in the adult heart (Kato and Kimura 1985;
Haimoto and Kato 1987), where it resides at high concen-
trations (Haimoto and Kato 1988). Because proline-rich
regions, such as titin’s PEVK domain often bind multiple
ligands, we tested whether S100A1 can bind to the cardiac
PEVK domain using an overlay technique (Kincaid et al.,
1988). Binding curves (Fig. 6) were obtained in the pres-
ence (0.1 mM CaCl2) and absence (1 mM EGTA) of cal-
cium, yielding half-maximal binding values of 42.5 and
120.7 nM with and without calcium, respectively (because
the binding curve determined in the presence of 1 mM
EGTA is not well-saturated, the value obtained at low
calcium should be considered a rough estimate). These
FIGURE 4 In vitro motility assay. Circles: F-actin sliding velocities
were measured over surfaces coated with either HMM (0 nM I27-PEVK-
I84) or a mixture of HMM and varying concentrations of I27-PEVK-I84
(100–475 nM). I27-PEVK-I84 inhibited velocities in a concentration-
dependant manner, with a 475 nM concentration of the fragment resulting
in an 70% reduction in velocity. Square: A four Ig-like domain fragment
(I91–I94) from titin’s proximal tandem Ig segment did not effect velocities
when added at the highest concentration used for I27-PEVK-I84 (475 nM).
Each data point represents the mean velocity for n  75 filaments. Error
bars are  SD.
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results indicate that S100A1 binds to the PEVK fragment in
a calcium-dependent manner.
To test whether the binding observed in vitro occurs in
the intact sarcomere, skinned mouse ventricular muscle
strips were incubated with S100A1 in the presence of
calcium, and bound proteins were detected using im-
muno-electron microscopy (IEM) with an antibody spe-
cific to the S100 -subunit. Labeling varied (most likely
due to variation in skinning and antibody penetration) but
was typically observed at the periphery of the M-lines,
and in the myofibrillar I-bands and A-bands (Fig. 7 C; for
discussion of A-band labeling, see below). In the I-band,
three labeled regions could be distinguished (Fig. 7 C)
whose positions varied with SL (Fig. 7 D), suggesting
that they label titin rather than the proteins of the thin
filament.
FIGURE 5 Myocyte mechanics. (A) Passive tension–SL curves were measured for a representative cell in relaxing solution (triangles), after a 40-min
incubation with I27-PEVK-I84 (squares), and after washout of the fragment (circles). I27-PEVK-I84 incubation resulted in a reversible decrease in passive
tension. (B) Mean passive tensions measured for all cells (n  5) as a function of SL (normalized to the control values for each cell). I27-PEVK-I84
decreased passive tension by 20% (circles) relative to the control across all SLs, with the magnitude of the decrease inversely related to SL. Across all
SLs upon washout of the fragment (squares), 45% of the decrease was recovered. Passive tensions in the presence of I27-PEVK-I84 were compared to
both the control and washout using a Dunnet’s test. Asterisks denote a significant (p 	 0.05) difference from the control, and error bars are  (washout)
or  (I27-PEVK-I84) SEM.
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In previous work, the extensible behaviors of the mo-
lecular subdomains comprising N2B titin’s elastic region
were characterized, including the PEVK domain (Trom-
bitas et al., 1999). Sequence-specific antibodies were
used to label the boundaries of each segment, and the
positions of the epitopes were measured as a function of
SL using IEM. Comparing the mobility of the S100
epitopes with those demarcating titin’s elastic subdo-
mains allowed us to estimate the locations of the S100
binding sites along the titin molecule. Figure 7 D shows
the mobilities of the S100 epitopes overlaid with those of
epitopes marking the boundaries of titin’s various sub-
domains. The data reveal S100 binding within the PEVK
domain, as well as within the 572-residue unique se-
quence of the N2B element and the C-terminal region of
the proximal tandem Ig segment. The binding observed in
situ is thus consistent with the in vitro results (Fig. 6),
and suggests that S100A1 binds the PEVK domain of
N2B titin. Interestingly, S100 also targets the unique
N2B segment whose extension, along with the PEVK
domain, accounts for the majority of the titin-based pas-
sive tension generated over the physiological SL range
(Helmes et al., 1999; Linke et al., 1999).
S100A1 inhibits PEVK–actin interaction in a
calcium-dependent manner
To determine whether S100 binding modulates the PEVK
domain’s actin-binding properties, a series of experiments
were performed using the fluorescent surface binding assay.
PEVK-coated coverslips were incubated with S100,
washed, and then incubated with F-actin. Figure 8 A shows
the relative degree of actin binding as a function of S100
concentration in the presence (0.1 mM CaCl2) and absence
(1 mM EGTA) of calcium. There was no significant differ-
ence in actin binding at high and low levels of calcium in
the absence of S100. This finding is in agreement with the
co-sedimentation results that found no calcium effect on
PEVK–actin binding affinity (Fig. 2 B). Pre-incubating the
PEVK fragment with S100A1, however, inhibited binding
in a concentration-dependent manner. Moreover, this inhi-
bition was greatly enhanced by calcium. Actin–PEVK bind-
FIGURE 6 Gel overlay analysis. Biotinylated-S100A1 was allowed to bind to I27-PEVK-I84 (1 g/lane) immobilized on a PVDF membrane, in the
presence (0.1 mM CaCl2) or absence (1 mM EGTA) of calcium. Bound S100 was detected with an avidin/alkaline phosphatase and a colorimetric substrate.
Band intensities were determined via densitometry, and fitted with a saturable binding function, giving half-maximal binding values of 40 nM and 120
nM and saturation values of 1200 OD/cm2 and 400 OD/cm2 in the presence and absence of calcium, respectively.
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FIGURE 7 Immuno-electron microscopy. A–C, Electron micrographs of mouse left ventricular muscle strips. (A) Strips incubated with 7.5 M S100A1
at pCa 9. The majority of sarcomeres did not contain S100 epitopes (top), although, occasional, sarcomeres displayed spotty labeling (bottom). (B) Control
strips incubated at pCa 4.5 without S100 showed no labeling. A similar absence of labeling was seen at pCa 9 (not shown). (C) Strips incubated with 7.5
M S100A1 at pCa 4.5. Several labeled regions could be distinguished in the central I-band region, each of which were mobile with respect to the Z-line
at varying degrees of sarcomere stretch (top, middle). Bottom micrograph shows that labeling was also observed in the inner 3/4 (indicated by thick line)
of the A-band (arrow bars) in a region that includes the C-zone, as well as near the periphery of the M-line (arrows). The near M-line epitopes are 69 
0.8 nm (n  17) apart. Calibration bar: 1 m for all micrographs except for bottom micrograph of C, which is 0.5 m. (D) Distances between the midpoint
of the I-band labeled regions and the middle of the Z-line as a function of I-band width. Lines indicate previously determined (Trombitas et al., 1999) linear
regression fits of epitopes marking the ends of the PEVK domain (I84–I86 and N2Bc) and the 572-residue unique N2B sequence (N2Bc and N2Bn). The
S100 epitope mobilities are consistent with binding to the C-terminal end of the proximal tandem Ig (red symbols), the unique N2B sequence (blue symbols),
and the PEVK domain (yellow symbols). Inset: Schematic of titin’s I-band domain organization showing the locations of the N2Bn, N2Bc, and I84–I86
antigens.
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ing was significantly reduced at high calcium relative to that
measured at low calcium for all concentrations of S100
used. At an S100:PEVK molar ratio of approximately 1:1
(340 nM S100), PEVK–actin binding was almost com-
pletely abolished (3% of control value) in the presence of
calcium. In light of our S100–PEVK binding results (Figs.
6 and 7), the observed decrease is likely due to a direct
interaction between S100A1 and the PEVK fragment that
prevents actin-PEVK binding.
In Fig. 8 B, the effect of S100 on PEVK–actin interaction
was measured as a function of calcium concentration. F-
actin was allowed to bind to a PEVK-coated surface that
was pre-incubated with a fixed concentration of S100 at pCa
levels ranging from 9 to 4.5. Relative to the value at pCa 9,
actin binding was reduced by 30% and 60% at pCa
values of 5.5 and 4.5, respectively. The pCa range in which
this effect was detected is within the range where half-
maximal activation occurs in intact cardiac muscle (Bers
2000), and coincides with previous work that demonstrates
that S100A1 binds calcium and undergoes conformational
changes within the pCa range from 6–4 (Baudier et al.,
1986). Moreover, Baudier et al. also demonstrated that the
presence of free [Mg2] decreases the affinity of S100A1
for calcium. Because the free [Mg2] in our experiments
(1.5 mM) likely exceeds that found in the working myo-
cyte (0.5–1.0 mM; see e.g., Silverman et al., 1994;
Freudenrich et al., 1992), the pCa range in which we de-
tected the reduction in binding may be underestimated.
Calcium/S100A1 alleviates PEVK-based
motility inhibition
In the previous motility experiments (Fig. 4) PEVK–actin
interaction resulted in a force that opposed the sliding of
actin filaments relative to the PEVK domain. From our
binding studies (Fig. 8), one would expect the inhibition of
HMM-driven motility to be alleviated in the presence of
S100A1 and calcium. This hypothesis was tested by mea-
suring the velocities of actin filaments sliding over a surface
that was coated with either HMM or a mixture of HMM and
the PEVK fragment, and was pre-incubated (before the
addition of F-actin) with and without S100A1 in the pres-
ence of 0.1 mM CaCl2. In the absence of S100, the PEVK
fragment inhibited F-actin velocity by 50% of the control
value (Fig. 9, middle versus top panels). When the HMM/
PEVK-coated surface was pre-incubated with S100A1, the
velocity was150% of the value obtained without S100 (in
the presence PEVK), representing a 50% recovery of the
PEVK-based inhibition (Fig. 9, middle versus bottom pan-
els). This recovery requires S100A1, because calcium alone
had no effect on F-actin velocities measured in the presence
of the PEVK fragment (2.3 m/s  0.6 (SD) versus 2.6
m/s  0.7 (SD) in the presence and absence of calcium,
respectively). This result is consistent with the in vitro
binding data, which failed to detect an effect of calcium on
PEVK–actin interaction (Figs. 2 B and 8 A). To exclude an
HMM-mediated effect of S100, control experiments were
performed in which S100A1 was added in the absence of
the PEVK fragment. There was no significant difference in
the mean velocity measured in these experiments (4.4 m/
s  0.4 (SD)) compared to that measured with HMM only
FIGURE 8 S100A1 inhibits actin-PEVK interaction. I27-PEVK-I84-
coated surfaces (0.3 M) were incubated with S100A1, washed, and then
incubated with fluorescently labeled F-actin. (A) Actin-PEVK binding as a
function of S100A1 concentration in the presence (0.1 mM CaCl2; squares)
or absence (1 mM EGTA; circles) of calcium. In control experiments (0
nM S100), PEVK–actin interaction was unaffected by calcium. S100A1
inhibited PEVK–actin interaction in a concentration-dependant manner,
with the degree of inhibition significantly enhanced by calcium at each
S100A1 concentration tested. Data points represent the mean number of
filaments bound per FOV for n 7 experiments, with 20 FOV/experiment.
Values  calcium were compared with a Student’s t-test, and statistically
significant (p 	 0.05) differences are denoted with asterisks. Error bars
are  SD. (B) F-actin binding to PEVK-coated surfaces that were pre-
incubated with a fixed concentration of S100A1 (170 nM) at a range of pCa
values. Relative to the value at pCa 9, binding was significantly (p 	 0.05)
reduced at pCa values of 5.5 and 4.5. Data points represent the mean
number of actin filaments bound per FOV for n  9 experiments, with 20
FOV/experiment. pCa 9 values were compared to pCa 7.5–4.5 values
using a Dunnet’s test. Error bars are SD.
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(4.6 m/s 0.5 (SD)). In summary, although calcium alone
does not affect PEVK–actin interaction, calcium/S100A1
inhibits PEVK–actin interaction, and alleviates PEVK-
based inhibition of in vitro motility.
DISCUSSION
We surveyed the subdomains of titin’s extensible region for
binding interactions with F-actin, which could potentially
modulate titin’s elastic properties. The existence of such
interactions is suggested by previous work on rat cardiac
myocytes (Granzier et al., 1997; Trombitas and Granzier
1997) in which thin filament extraction from the extensible
region of titin resulted in a significant passive tension re-
duction at SLs2.0 m. Because the tandem Ig segments
are nearly straight at these SLs, the effect was unlikely to
result from interaction between actin and the tandem Ig
segments (Granzier et al., 1997). In agreement with this
notion are the results from the present study that failed to
detect binding between actin and a fragment encompassing
8 Ig repeats from the distal tandem Ig segment (Fig. 2 A),
and the results of others (Linke et al., 1997). At SLs above
2.0 m, passive force is determined by extension of the
PEVK segment and the N2B unique sequence (Trombitas et
al., 1999). Although no binding was detected between actin
and the N2B unique sequence (Fig. 2 A), we demonstrate
that a recombinant cardiac PEVK fragment binds readily to
F-actin. These results are in agreement with the recent
findings of Linke and co-workers (Kulke et al., 2001), who
also reported binding between the cardiac PEVK domain
and F-actin. A possible explanation for an earlier study,
which did not detect binding between the N2B PEVK
domain and F-actin (Linke et al., 1997) may be the inherent
difficulties in expressing and purifying the PEVK region of
titin.
In the present study, the interaction between the PEVK
domain and F-actin was characterized, and its physiological
significance investigated using a multi-faceted approach,
including in vitro binding assays, in vitro motility, myocyte
mechanics, and immunoelectron microscopy. Our findings
indicate that a dynamic interaction between the PEVK do-
main and F-actin makes a significant contribution to the
passive tension. Evidence that PEVK–actin interaction can
be regulated in a calcium-sensitive manner by the soluble
calcium-binding protein S100A1 is also provided.
Mechanism underlying PEVK–actin interaction
F-actin contains a large patch of negatively charged residues
on its exposed surface (Kabsch et al., 1990), and several
actin-binding proteins are known to bind to this region via
basic charge clusters (e.g., Friederich et al., 1992; Pfuhl et
al., 1994; Fulgenzi et al., 1998). The results of our binding
studies suggest that PEVK-actin interaction also includes an
electrostatic component. Both the skeletal and cardiac
PEVK fragments exhibited decreased binding in response to
increased IS, with the skeletal PEVK exhibiting weaker
binding at intermediate IS and a greatly enhanced IS sensi-
tivity (Fig. 3 B). Only the cardiac N2B PEVK bound F-actin
at physiological IS s. These differences in actin-binding
affinity may be explained by their different charge charac-
teristics of the cardiac and skeletal PEVK fragments, which
have theoretical isoelectric points (pI) of 9.7 and 8.0, re-
spectively. At physiological pH, the cardiac PEVK there-
fore carries a greater net positive charge, which likely
FIGURE 9 Calcium/S100A1 alleviates PEVK-based inhibition of in
vitro motility. F-actin velocities were measured over surfaces coated with
either HMM (top) or a mixture of HMM and I27-PEVK-I84 (middle and
bottom) in the presence of 0.1 mM CaCl2. I27-PEVK-I84 (450 nM)
inhibited sliding velocities by 50% relative to the control (2.3  0.6
m/s versus 4.6  0.5 m/s in PEVK-treated and control, respectively
(SD)). Calcium/S100A1 (3 M) alleviated the PEVK-based motility
inhibition by 50%, to 3.5  0.4 m/s (SD). Each histogram contains
velocities pooled from n  3 experiments, with 75 filaments/experiment
(225 total filaments). PEVK velocities (middle) were determined to be
significantly different from both the control (top) and the PEVK  S100
(bottom) using a Dunnet’s test (p 	 0.05).
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facilitates its interaction with the negatively charged actin
filament.
Assuming that the actin-binding propensity of the PEVK
domain is indeed related to its net charge, it is possible to
make predictions about the binding properties of the PEVK
domains expressed in different titin isoforms. The majority
of the PEVK sequences in all titin isoforms are comprised
of basic (pI  9–10) 27–28-residue repeats, termed PPAK
repeats, that are rich in proline (Greaser, 2001). In addition,
the larger versions of the PEVK domain expressed in skel-
etal titins and the cardiac N2BA isoform contain highly
acidic (pI  4.0) polyglutamic acid (E) regions interspersed
with the PPAK repeats (Greaser, 2001). The presence of the
poly-E regions gives the larger PEVK isoforms a net acidic
character. For example, the soleus muscle PEVK has a
predicted pI of 5.1. In contrast, the cardiac N2B PEVK lacks
poly-E segments and has a pI (9.70) that is characteristic of
the PPAK repeats that comprise 75% of its primary struc-
ture. The cardiac N2B PEVK may therefore be unique
among the PEVK isoforms in its ability to bind actin.
However, a conclusive determination of whether the PEVK
domains of skeletal muscle titins can bind actin will require
future studies using constructs that include the full-length
versions of the PEVK expressed in each titin isoform.
In addition to their net positive charge, the PPAK repeats
are also rich in proline (25%). Proline-rich regions (PRRs)
often assume extended conformations, such as the poly-
proline II (PPII)-helix that was recently predicted for skel-
etal muscle PEVK fragments (Gutierrez-Cruz et al., 2000;
Ma et al., 2001). Due to the conformational restrictions that
proline residues impose on the polypeptide backbone, PRRs
experience a relatively small reduction of entropy upon
ligand binding (Williamson 1994). This property makes
them energetically favorable sites for protein-protein inter-
actions, and there are numerous examples of PRRs that
perform binding functions in vivo (for review, see William-
son 1994). The binding of actin by the PPAK-rich N2B
PEVK may therefore be both electrostatically and thermo-
dynamically favorable.
Physiological significance of
PEVK–actin interaction
As the myocardium is passively stretched during diastole,
the thin filaments are translated relative to the PEVK do-
main. We investigated how PEVK–actin interaction might
influence this process using an in vitro motility assay tech-
nique in which F-actin was propelled over a surface coated
with either HMM alone or a mixture of HMM and the
PEVK fragment. The addition of the PEVK fragment in-
hibited F-actin velocities in a concentration-dependent man-
ner (Fig. 4). The inhibition is likely due to a tethering
mechanism similar to that proposed in previous titin-related
motility studies (Li et al., 1995; Kellermayer and Granzier
1996a). Because F-actin readily binds to the PEVK frag-
ment in the fluorescent surface-binding assay (Figs. 3 and
8), a similar interaction could transiently tether the motile
actin filaments to the surface of the assay chamber via
surface-bound PEVK fragments. An HMM-based effect on
velocity is unlikely because HMM does not bind to the
PEVK fragment, and mixtures of HMM and a similar-sized
fragment containing only Ig-like domains had no effect on
velocity (Fig. 4). Moreover, studies have shown that actin
velocities are independent of HMM surface density over a
wide range of HMM concentrations (Homsher et al., 1993).
The proposed mechanism of motility inhibition, in which a
dynamic interaction between the PEVK domain and F-actin
results in a force that opposes HMM-driven motility, is also
supported by the reversibility of inhibition in the presence
of calcium/S100 (see below).
To determine whether PEVK–actin interaction affects
passive tension generation, mechanical experiments with
mouse cardiac myocytes were conducted, in which I27-
PEVK-I84 was added to skinned myocytes to compete with
endogenous titin molecules for binding sites on the thin
filament. The presence of I27-PEVK-I84 significantly re-
duced passive tension at all SLs, with a mean reduction of
20%, whereas washout of the fragment led to a mean
passive tension recovery of 45%. Passive tension in
skinned myocytes is almost entirely due to the extension of
titin’s I-band spanning segment (Granzier and Irving 1995),
and the significant reduction of passive tension in the pres-
ence of I27-PEVK-I84 can therefore be considered a titin-
based effect. Because binding was detected only in the
PEVK region of titin’s extensible segment (Fig. 2 A), we
conclude that PEVK–actin interactions in the sarcomere
(which are likely abolished by the addition of the PEVK
fragment) make a significant contribution to the passive
tension.
It is possible, however, that the exogenous PEVK frag-
ment could also compete off other interactions in the sar-
comere. For example, a segment of titin located near the
Z-line is known to strongly associate with the thin filament
(Linke et al., 1997; Trombitas and Granzier 1997), and this
interaction could be reversibly uncoupled during I27-
PEVK-I84 incubation and washout. This possibility is un-
likely though, because the abolishment of titin–actin inter-
action near the Z-line via extensive gelsolin extraction
recruits the near Z-line titin into the extensible pool, leading
to an increase (rather than a decrease) in passive tension at
SLs between slack and 2.2 m (Granzier et al., 1997). It is
also possible that I27-PEVK-I84 inhibits binding between
the thin filament and the I111–I112 region of titin, which
has been shown previously to bind F-actin (Jin, 1995).
However, an effect of I111–I112–actin binding on passive
tension is not consistent with the sarcomeric location of the
I111–I112 region of titin, which is not extensible in mouse
cardiac muscle (Trombitas et al., 2000). A potential expla-
nation for the lack of a full recovery of passive tension upon
washout of I27-PEVK-I84 could be related to a small de-
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crease in passive tension that was observed in parallel
control experiments in which the PEVK fragment was omit-
ted (not shown). This decrease is likely due to “run-down”
during the protocol, because we did not witness any recov-
ery of passive tension in the control.
A mechanism by which PEVK–actin interaction could
contribute to passive tension in cardiac myocytes is sug-
gested by the motility results, which show that PEVK–actin
interaction results in a force that opposes the sliding of actin
relative to titin. The SL-dependence of the passive tension
decrease measured in the myocyte experiments is consistent
with this hypothesis, because the PEVK domain may have
less lateral freedom to interact with the thin filament as it
becomes fully extended at longer SLs. Binding between
titin and the thin filament could also effectively shorten the
length of titin’s extensible region, resulting in higher frac-
tional extensions at a given SL. As shown previously (Gran-
zier et al., 1997; Kellermayer et al., 1997; Trombitas et al.,
1998b), the fractional extensions of titin’s extensible seg-
ments correlate with the magnitude of passive tension.
S100A1 as a potential regulator of
PEVK–actin interaction
S100A1 resides at high concentrations in striated muscles
(Kato and Kimura 1985), and has been shown to bind to the
SR-ryanodine receptor (Treves et al., 1997), the actin-cap-
ping protein Cap-Z (Ivanenkov et al., 1996), nebulin (Gu-
tierrez-Cruz et al., 2000), and the kinase domain of the
titin-related protein twitchin (Heierhorst et al., 1996). Here,
we show that S100A1 can bind to the N2B PEVK domain
both in vitro and in situ. The in vitro results (Figs. 6 and 8)
reveal that the binding of S100A1 to the PEVK domain
inhibits PEVK-actin interaction in a calcium-sensitive man-
ner. These findings, and the results of others (Zimmer
1991), suggest that F-actin does not bind to S100A1. How-
ever, in light of a recent report of S100A1 interaction with
F-actin (Mandinova et al., 1998), this possibility was tested
in both the co-sedimentation assay and the visual surface-
binding assay (data not shown). No binding was detected
between F-actin and S100A1 in either the presence (0.1 mM
CaCl2) or absence (1 mM EGTA) of calcium.
Previous S100A1 binding studies have deduced a con-
sensus sequence ((K/R)(L/I)XWXXIL) for S100A1 recog-
nition (Ivanenkov et al., 1996), and S100A1 interactions
with proteins containing the consensus can be inhibited by
a peptide called TRTK-12 (Garbuglia et al., 1999). Al-
though the PEVK domain lacks this consensus sequence,
there are several reports of S100A1 interactions with targets
that also lack a consensus site and that are unaffected by
TRTK-12 (Treves et al., 1997; Garbuglia et al., 2000). It
thus appears that S100A1 can bind its target proteins via
multiple mechanisms, and the sequence and structural de-
terminants for its target recognition are not yet fully under-
stood.
Reports of S100A1 binding to protein domains that also
bind calmodulin (Baudier et al., 1987; Heierhorst et al.,
1996; Treves et al., 1997) may give insights into S100A1–
PEVK interaction. Calmodulin is known to bind amphiphi-
lic helices on its target proteins (for review, see O’Neil and
DeGrado 1990). PPII-helices can also have amphiphilic
properties (Stapley and Creamer 1999), and a PEVK PPAK-
repeat was recently determined to contain substantial PPII-
helix content (Gutierrez-Cruz et al., 2000; Ma et al., 2001).
Considering that PPAK repeats comprise75% of the N2B
PEVK (Greaser, 2001), and, given its abundance of charged
and hydrophobic residues (40% charged and 22% hy-
drophobic), it is possible that the N2B PEVK contains
PPII-helices with amphiphilic properties. Future studies
aimed at defining the S100A1 binding site(s) within the
PEVK domain could establish whether S100A1 does indeed
bind to such regions.
Immunolabeling revealed that S100A1 binds at several
locations in the I-band and A-band of mouse cardiac muscle
in the presence of calcium (Fig. 7). It is unlikely that I-band
binding results from interaction between S100A1 and the
thin filament because the positions of the S100A1 epitopes
changed with respect to the Z-line as sarcomeres were
stretched (Fig. 7, C and D). Instead, the mobility of the S100
binding sites indicates binding between S100A1 and the
I-band region of titin. Whether the binding partner in the
A-band is also titin or another thick-filament protein re-
mains to be established. If S100A1 does bind titin in the
A-band, the location of the binding sites suggests interac-
tion with titin’s super-repeat domains (located in the C-zone
of the A-band) and a region 15-nm C-terminal of titin’s
kinase domain (located 50 nm from the center of the
A-band; Obermann et al., 1997). Comparing the positions of
the I-band S100 binding sites as a function of SL with those
of epitopes marking the various segments within titin’s
extensible region suggests that S100 binds to the PEVK
domain, the N2B unique sequence and the C-terminal re-
gion of the proximal tandem Ig segment.
A functional role for S100A1-PEVK binding is suggested
by our in vitro motility results, which show that calcium/
S100A1 can alleviate the PEVK-based inhibition of F-actin
motility (Fig. 9). By inhibiting PEVK–actin interaction,
calcium/S100A1 may provide the sarcomere with a mech-
anism to free the thin filament from titin before active
contraction and thereby reduce titin-based force. Consider-
ing that the cytosolic S100A1 is likely to be constant during
the heart’s pumping cycle, fluctuations in free calcium may
result in a cyclic regulation of PEVK–actin interaction. The
results of ter Keurs and co-workers, which demonstrate that
the stiffness of rat cardiac trabeculae increases as calcium
levels decay during the diastolic interval, are consistent with
this hypothesis (Stuyvers et al., 1997a,b, 1998, 2000). Fur-
ther testing of whether calcium/S100 regulates PEVK–actin
interaction in the sarcomere during systole would require
methods that allow the effects of S100A1 to be observed at
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high calcium levels, without interference from active con-
traction. Although methods exist for depressing actomyosin
interaction (Zhao et al., 1995; Meyer et al., 1998), they do
not completely abolish active force development, and their
effect on PEVK–actin interaction is unknown. Future work
is therefore needed to elucidate the full functional signifi-
cance of calcium/S100-based regulation of PEVK–actin in-
teraction.
In summary, our findings show that cardiac titin’s PEVK
domain binds F-actin, and that this interaction is a signifi-
cant contributor to the passive tension. We also show that
S100A1 can bind to the PEVK domain both in vitro and in
situ. S100 binding inhibits PEVK–actin interaction, and
may aid in freeing the thin filament from titin before active
contraction. The targeting of S100A1 to titin’s primary
force-generating elements (the N2B element and the PEVK
domain) suggests that S100A1 may be an important regu-
lator of titin’s intrinsic elastic properties, and its interactions
with other proteins.
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